These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16144914)

  • 1. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
    Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
    Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
    Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
    Clin Breast Cancer; 2021 Oct; 21(5):399-407.e2. PubMed ID: 33386231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efp as a primary estrogen-responsive gene in human breast cancer.
    Ikeda K; Orimo A; Higashi Y; Muramatsu M; Inoue S
    FEBS Lett; 2000 Apr; 472(1):9-13. PubMed ID: 10781795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.
    Urano T; Saito T; Tsukui T; Fujita M; Hosoi T; Muramatsu M; Ouchi Y; Inoue S
    Nature; 2002 Jun; 417(6891):871-5. PubMed ID: 12075357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic distribution of estrogen-responsive finger protein (Efp) in human tissues.
    Shimada N; Suzuki T; Inoue S; Kato K; Imatani A; Sekine H; Ohara S; Shimosegawa T; Sasano H
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):147-53. PubMed ID: 15130519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
    Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N
    Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
    Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
    Nakayama H; Sano T; Motegi A; Oyama T; Nakajima T
    Pathol Int; 2005 Nov; 55(11):707-15. PubMed ID: 16271083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
    Suzuki T; Nakata T; Miki Y; Kaneko C; Moriya T; Ishida T; Akinaga S; Hirakawa H; Kimura M; Sasano H
    Cancer Res; 2003 Jun; 63(11):2762-70. PubMed ID: 12782580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
    Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
    Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
    Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low PBRM1 identifies tumor progression and poor prognosis in breast cancer.
    Mo D; Li C; Liang J; Shi Q; Su N; Luo S; Zeng T; Li X
    Int J Clin Exp Pathol; 2015; 8(8):9307-13. PubMed ID: 26464681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of estrogen-responsive finger protein expression in benign and malignant human breast.
    Thomson SD; Ali S; Pickles L; Taylor J; Pace PE; Lymboura M; Shousha S; Coombes RC
    Int J Cancer; 2001 Jan; 91(2):152-8. PubMed ID: 11146438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
    Dai H; Zhang P; Zhao S; Zhang J; Wang B
    Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
    Song J; Bai J; Yang W; Gabrielson EW; Chan DW; Zhang Z
    Histopathology; 2007 Jul; 51(1):40-53. PubMed ID: 17593079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
    Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of rat efp: expression and regulation in primary osteoblasts.
    Inoue S; Urano T; Ogawa S; Saito T; Orimo A; Hosoi T; Ouchi Y; Muramatsu M
    Biochem Biophys Res Commun; 1999 Aug; 261(2):412-8. PubMed ID: 10425199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
    Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
    Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.